APA (7th ed.) Citation

de Hoon, J., Van Hecken, A., Vandermeulen, C., Herbots, M., Kubo, Y., Lee, E., . . . Gabriel, K. (2019). Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers. Cephalalgia, 39(1), 100-110. https://doi.org/10.1177/0333102418776017

Chicago Style (17th ed.) Citation

de Hoon, Jan, Anne Van Hecken, Corinne Vandermeulen, Marissa Herbots, Yumi Kubo, Ed Lee, Osa Eisele, Gabriel Vargas, and Kristin Gabriel. "Phase 1, Randomized, Parallel-group, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Erenumab (AMG 334) and Concomitant Sumatriptan on Blood Pressure in Healthy Volunteers." Cephalalgia 39, no. 1 (2019): 100-110. https://doi.org/10.1177/0333102418776017.

MLA (9th ed.) Citation

de Hoon, Jan, et al. "Phase 1, Randomized, Parallel-group, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Erenumab (AMG 334) and Concomitant Sumatriptan on Blood Pressure in Healthy Volunteers." Cephalalgia, vol. 39, no. 1, 2019, pp. 100-110, https://doi.org/10.1177/0333102418776017.